Stem Cell Reports (Dec 2019)

Precision Health Resource of Control iPSC Lines for Versatile Multilineage Differentiation

  • Matthew R. Hildebrandt,
  • Miriam S. Reuter,
  • Wei Wei,
  • Naeimeh Tayebi,
  • Jiajie Liu,
  • Sazia Sharmin,
  • Jaap Mulder,
  • L. Stephen Lesperance,
  • Patrick M. Brauer,
  • Rebecca S.F. Mok,
  • Caroline Kinnear,
  • Alina Piekna,
  • Asli Romm,
  • Jennifer Howe,
  • Peter Pasceri,
  • Guoliang Meng,
  • Matthew Rozycki,
  • Deivid C. Rodrigues,
  • Elisa C. Martinez,
  • Michael J. Szego,
  • Juan C. Zúñiga-Pflücker,
  • Michele K. Anderson,
  • Steven A. Prescott,
  • Norman D. Rosenblum,
  • Binita M. Kamath,
  • Seema Mital,
  • Stephen W. Scherer,
  • James Ellis

Journal volume & issue
Vol. 13, no. 6
pp. 1126 – 1141

Abstract

Read online

Summary: Induced pluripotent stem cells (iPSC) derived from healthy individuals are important controls for disease-modeling studies. Here we apply precision health to create a high-quality resource of control iPSCs. Footprint-free lines were reprogrammed from four volunteers of the Personal Genome Project Canada (PGPC). Multilineage-directed differentiation efficiently produced functional cortical neurons, cardiomyocytes and hepatocytes. Pilot users demonstrated versatility by generating kidney organoids, T lymphocytes, and sensory neurons. A frameshift knockout was introduced into MYBPC3 and these cardiomyocytes exhibited the expected hypertrophic phenotype. Whole-genome sequencing-based annotation of PGPC lines revealed on average 20 coding variants. Importantly, nearly all annotated PGPC and HipSci lines harbored at least one pre-existing or acquired variant with cardiac, neurological, or other disease associations. Overall, PGPC lines were efficiently differentiated by multiple users into cells from six tissues for disease modeling, and variant-preferred healthy control lines were identified for specific disease settings. : Ellis, Scherer, and colleagues apply precision health to upgrade iPSC quality for disease modeling. The resource provides control lines from four healthy individuals, clinical annotation of whole-genome variants, and identification of variant-preferred lines for neurologic and cardiac disease. Resource users demonstrated versatile differentiation into functional cells from six tissues, and CRISPR-edited cells phenocopied a cardiomyopathy model. Keywords: Personal Genome Project Canada, control iPSCs, whole-genome sequencing, gene editing, cellular phenotyping, disease modeling